Profusa, Inc.

Profusa To Withdraw S-1 Registration Statement to Pursue a Smaller, More Focused Offering

Profusa Receives Purchase Orders for Lumee™ Tissue Oxygen Monitoring and Raises 2026 Revenue Guidance

Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies

Profusa Announces 1-for-75 Reverse Stock Split

Profusa Presents Positive US-Study Clinical Results at Leipzig Interventional Course (LINC) 2026